¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"RE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
  • JrId: 6911
    JournalTitle: Research on aging.
    MedAbbr: Res Aging
    ISSN: 0164-0275
    ESSN:
    IsoAbbr:
    NlmId: 7908221
  • JrId: 6912
    JournalTitle: Research progress in organic, biological and medicinal chemistry.
    MedAbbr: Res Prog Org Biol Med Chem
    ISSN: 0486-5111
    ESSN:
    IsoAbbr:
    NlmId: 43605
  • JrId: 6913
    JournalTitle: Research in immunology.
    MedAbbr: Res Immunol
    ISSN: 0923-2494
    ESSN:
    IsoAbbr: Res. Immunol.
    NlmId: 8907467
  • JrId: 6914
    JournalTitle: Research in microbiology.
    MedAbbr: Res Microbiol
    ISSN: 0923-2508
    ESSN:
    IsoAbbr: Res. Microbiol.
    NlmId: 8907468
  • JrId: 6915
    JournalTitle: Research publications - Association for Research in Nervous and Mental Disease.
    MedAbbr: Res Publ Assoc Res Nerv Ment Dis
    ISSN: 0091-7443
    ESSN:
    IsoAbbr:
    NlmId: 7505942
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • X62.1
    Residential institution
    Áý´Ü°ÅÁֽü³
  • W56.1
    Residential institution
    Áý´Ü°ÅÁֽü³
  • X37.1
    Residential institution
    Áý´Ü°ÅÁֽü³
  • W30.1
    Residential institution
    Áý´Ü°ÅÁֽü³
  • Y33.1
    Residential institution
    Áý´Ü°ÅÁֽü³
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • recumbent
    ´©¿î-, ±â´ë´©¿î-
  • recumbent position
    ´©¿îÀÚ¼¼
  • recuperation
    ȸº¹
  • recurettage
    µÇ±Ü¾î³¿(¼ú), Àç¼ÒÆÄ(¼ú)
  • recurrence
    Àç¹ß
  • recurrent
    1. µÇµ¹ÀÌ-, ¹Ýȸ-, ȸ±Í- 2. Àç¹ß-, ¹Ýº¹-
  • recurrent aphtha
    Àç¹ß¾ÆÇÁŸ
  • recurrent appendicitis
    Àç¹ßÃæ¼ö¿°
  • recurrent artery
    µÇµ¹À̵¿¸Æ, ¹Ýȸµ¿¸Æ
  • recurrent attack
    ¹Ýº¹¹ßÀÛ
  • recurrent bandage
    ¹ÝȸºØ´ë
  • recurrent cancer
    Àç¹ß¾Ï
  • recurrent dislocation
    Àç¹ßÅ»±¸
  • recurrent fever
    Àç¹ß¿­
  • recurrent inhibition
    ȸ±Í¾ïÁ¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • renin-secreting juxtaglomerular tumor
    ·¹´ÑºÐºñÅ丮°çÁ¾¾ç, ·¹´ÑºÐºñ»ç±¸Ã¼¿·Á¾¾ç
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð, ½ÅÀåÇ÷°ü°íÇ÷¾Ð
  • reossification
    »ÀÀç¹ß»ý, Àç°ñÈ­
  • reovirus
    ·¹¿À¹ÙÀÌ·¯½º
  • reoxidation
    Àç»êÈ­
  • repair
    º¹±¸, ¼öº¹, Ä¡À¯
  • reparation
    ¹è»ó
  • repeat cytology
    ¹Ýº¹¼¼Æ÷°Ë»ç
  • repeatability
    ¹Ýº¹¼º
  • repellent
    1.ÅðÄ¡Á¦, 2.ÅðÄ¡¼º
  • repercussive
    1.¼Ò¿°-, 2.ÅðÄ¡Á¦
  • repetition
    ¹Ýº¹
  • repetition time
    ¹Ýº¹½Ã°£
  • repetitive stimulation
    ¹Ýº¹ÀÚ±Ø
  • repigmentation
    »ö¼ÒÀçÄ§Âø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • rectotomy
    (¢¡proctotomy) °ðâÀÚÀý°³¼ú, Á÷ÀåÀý°³¼ú
  • rectourethral
    °ðâÀÚ¿äµµ-, Á÷Àå¿äµµ-
  • rectourethral fistula
    °ðâÀÚ¿äµµ»û±æ, Á÷Àå¿äµµ·ç
  • rectouterine
    °ðâÀÚÀÚ±Ã-, Á÷ÀåÀÚ±Ã-
  • rectouterine excavation
    °ðâÀÚÀڱÿÀ¸ñ
  • rectouterine fold
    °ðâÀÚÀÚ±ÃÁÖ¸§, Á÷ÀåÀÚ±ÃÁÖ¸§
  • rectouterine pouch
    °ðâÀÚÀڱÿÀ¸ñ
  • rectovaginal fistula
    °ðâÀÚÁú»û±æ, Á÷ÀåÁú·ç
  • rectovaginal septum
    °ðâÀÚÁú»çÀ̸·, Á÷ÀåÁúÁß°Ý
  • rectovaginoabdominal
    °ðâÀÚÁú¹èºÎ-, Á÷ÀåÁúº¹ºÎ-
  • rectovesical
    °ðâÀڹ汤-, Á÷À广±¤-
  • rectovesical excavation
    °ðâÀڹ汤¿À¸ñ
  • rectovesical fold
    °ðâÀڹ汤ÁÖ¸§, Á÷À广±¤ÁÖ¸§
  • rectovesical muscle
    °ðâÀڹ汤±Ù, Á÷À广±¤±Ù
  • rectovesical pouch
    °ðâÀڹ汤¿À¸ñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • recruitment factor
    ´©°¡¿äÀÎ(׫ʥé©ì×).
  • recruitment phenomenon
    Á¡ÁõÇö»ó(ïÂñòúÞßÚ), ´©°¡Çö»ó(׫ʥúÞßÚ), º¸ÃæÇö»ó( ÜÍõöúÞßÚ).
  • recruitment phenomenon
    ´©°¡Çö»ó
  • recrystallization
    Àç°áÁ¤(î¢Ì¿ïÒ).
  • rectal abscess
    Á÷Àå³ó¾ç(Á÷Àå³ó¾ç).
  • rectal abscess
    Á÷Àå³ó¾ç(òÁíóÒÛåË)
  • rectal aerophagia
    Á÷Àå³»°ø±âÈíÀÔ(¡­³»°ø±âÈíÀÔ).
  • rectal aganglionosis
    °ðâÀڽŰæÀý°á¿©Áõ
  • rectal alimentation
    Á÷À念¾ç¹ý(¡­¿µ¾ç¹ý).
  • rectal ampulla
    °ðâÀÚÆØ´ë
  • rectal ampulla ³ª a. recti
    Á÷À寨´ë, Á÷À寨´ëºÎ(òÁíóø³ÓÞÝ»).
  • rectal anesthesia
    Á÷À帶Ãë(¹ý)(¡­Ø«ö­Ûö).
  • rectal anesthetic
    Á÷À帶ÃëÁ¦<¾à>.
  • rectal application
    Á÷Àå³»Àû¿ë(¡­³»Àû¿ë).
  • rectal atresia
    Á÷ÀåÆó¼â(Á÷ÀåÆó¼â).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • recessus sacculi ³ª
    ¿øÇüÁÖ¸Ó´Ï¿À¸ñ, ±¸Çü³¶ÇÔ¿ä(Ϲû¡Ò¥ùèèê).
  • recessus sphenoethmoidalis ³ª
    Á¢Çü»ç°ñ¿À¸ñ, Á¢»çÇÔ¿ä(ïÊÞèùèèê).
  • recessus sphericus ³ª
    µÕ±Ù¿À¸ñ, ±¸Çü³¶ÇÔ¿ä(Ϲû¡Ò¥ùèèê).
  • recessus subhepatici ³ª
    °£¾Æ·¡¿À¸ñ, °£ÇÏÇÔ¿ä(ÊÜù»ùèèê).
  • recessus subphrenici ³ª
    Ⱦ°Ý¸·¾Æ·¡¿À¸ñ, Ⱦ°ÝÇÏÇÔ¿ä(üô̰ù»ùèèê).
  • recessus subpopliteus ³ª
    ¿À±Ý±Ù¾Æ·¡ÁÖ¸Ó´Ï, ½½¿Í±ÙÇÏÇÔ¿ä(ã£èÀÐÉù»ùèèê).
  • recessus triangularis ³ª
    »ï°¢¿À¸ñ, »ï°¢ÇÔ¿ä(ß²ÊÇùèèê).
  • recessus utriculi ³ª
    Ÿ¿øÁÖ¸Ó´Ï¿À¸ñ, ŸÇü³¶ÇÔ¿ä(NCû¡Ò¥ùèèê).
  • recessus vestibulo cochleare ³ª
    ÀüÁ¤´ÞÆØÀÌÇÔ¿ä, ÀüÁ¤¿Í¿ìÇÔ¿ä(îñïÔèÄéÚùè èê).
  • recessus zygomaticus ³ª
    ±Ç°ñ¿À¸ñ, Çù°ñ¿Í( ÍéèÀ).
  • recessus ³ª
    ¿À¸ñ, ÇÔ¿ä.
  • recipient
    ¼ö¿ëÀÚ, ¹Þ´ÂÀÚ, ÇÇÀü´ÞÀÚ
  • recipiomotor
    ¿îµ¿Ãæ°Ý¼ö¿ëÀÇ.
  • reciprocal anchorage
    »ó¹Ý°íÁ¤(ßÓÚãͳïÒ), ±³Á¤(Îìïá).
  • reciprocal articulation
    »óÈ£ °üÀý(ßÓû»Î¼ï½), »ó°ü °üÀý(ßÓμμï½).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • resinate
    ¼öÁö¿°(ç¤)
  • resinoid
    ·¹½Ã³ëÀ̵å
  • resistance
    ÀúÇ×(î½ù÷)
  • resistance factor
    ÀúÇ× ÀÎÀÚ(ì×í­)
  • resistance-transfer factor
    ÀúÇ×ÀüÀÌ ÀÎÀÚ(ï®ì¹ì×í­)
  • resolution
    "ºÐ¸®(ÝÂ×î), ºÐÇÒ(ÝÂùÜ), ÇØ»ó(ú°ßÚ)"
  • resolvase
    ¸®¼Öº£À̽º
  • resolving gel
    ºÐ¸®(ÝÂ×î)Á©
  • resolving power
    "ºÐ¸®´É(ÝÂ×îÒö), ºÐÇØ´É(ÝÂú°Òö), ÇØ»ó´É(ú°ßÚÒö)"
  • resolving time
    "ºÐ¸®½Ã°£, ÇØ»ó½Ã°£"
  • resonance
    °ø¸í(ÍìÙ°)
  • resonance energy transfer
    °ø¸í(ÍìÙ°) ¿¡³ÊÁö ÀüÀÌ(ï®ì¹)
  • resonance hybrid
    °ø¸í(ÍìÙ°) Æ¢±â
  • resonance Raman spectroscopy
    °ø¸í ¶ó¸¸ ºÐ±¤¹ý(ÝÂÎÃÛö)
  • resonance stabilization
    °ø¸í ¾ÈÁ¤È­(äÌïÒûù)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • retained placenta
    ÀÜ·ùŹÝ
  • retained testicle
    Á¤·ù°íȯ
  • retardation
    Áö¿¬, ÁöÁø, Áöü, Áö¿Ï
  • retarded
    Áö¿¬(µÈ)
  • rete
    ±×¹°, ¸Á
  • rete mirabile
    ¼Òµ¿Á¤¸Æ±×¹°, ±«¸Á, ¹Ì¸Á
  • retention
    Á¤Ã¼, ü·ù, º¸·ù
  • retention cyst
    Àú·ù³¶,ÀÜ·ù³¶
  • reticular
    ¸Á»óÀÇ
  • reticular connective tissue
    ¼¼¸Á°áÇÕÁ¶Á÷
  • reticular density
    ¸Á»óÀ½¿µ
  • reticular fiber
    ¼¼¸Á¼¶À¯
  • reticular tissue
    ¼¼¸ÁÁ¶Á÷
  • reticulocyte
    ¸Á»ó(ÀûÇ÷)±¸
  • reticulocytosis
    ¸Á»óÀûÇ÷±¸ Áõ°¡Áõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • regression estimate
    ȸ±Í ÃßÁ¤·®
  • regressive
    ÅðÇ༺ÀÇ, ȸ±Í¼ºÀÇ
    °¨ÅðÀû, ÅðÇà, ȸ±Í¸¦ Ư¡À¸·Î ÇÏ´Â.
  • regressive change
    ÅðÇ༺ º¯È­
  • regressive infantilism
    ÅðÇ༺ À¯Ä¡Áõ
  • regular control
    ±ÔÄ¢ÀûÀÎ Á¶Àý
  • regular exercise
    ±ÔÄ¢ÀûÀÎ ¿îµ¿
  • regulation of body temperature
    ü¿Â Á¶Àý
  • regulator gene
    Á¶Àý À¯ÀüÀÚ
  • regulatory gene
    Á¶Àý À¯ÀüÀÚ
  • regurgitation jaundice
    ¿ª·ù¼º Ȳ´Þ
  • rehabilitation center
    ÀçȰ¿ø
  • rehabilitative therapy
    ÀçÆÈ ¿ä¹ý
  • rehydration
    Àç¼öÈ­ ÀÛ¿ë
    ½Åü³ª Å»¼öµÈ ¹°Ã¼ÀÇ ¼öºÐ, ¾×üÀÇ ÇÔ·®À» ȸº¹ º¸Á¸½ÃŰ´Â °Í.
  • Reifenstein's syndrome
    ¶óÀÌÆæ½ºÅ¸ÀÎ ÁõÈıº
    °¡Á·¼º ³²¼º °¡¼º ¹ÝÀ½¾ç ÁõÈıºÀ¸·Î ¿äµµÇÏ¿­ ¿ø¹ß¼º ¼º±â´É ºÎÀü, »çÃá±â ÈÄÀÇ °íȯ À§Ãà ¹× ¹«Á¤ÀÚÁõ, testosterone °áÇÌ Â¡ÈÄ ±×¸®°í Á¾Á¾ ¿©¼ºÇü À¯¹æ µîÀ» Ư¡À¸·Î ÇÑ´Ù.
  • reimbursement
    ¹è»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
receptors, sensory Specialised neurons or parts of neurons which transduce sensory information and relay it centrally. Included are receptors for stimuli outside the body (exteroceptors) as well as receptors for stimuli from within the body itself (interoceptors and proprioceptors). Sensory receptors may include accessory structures which condition (e.g., filter) the input received by the receptor neurons themselves.
(12 Dec 1998)
receptors, serotonin Cell-surface proteins that bind serotonin and trigger intracellular changes which influence the behaviour of cells. Several types of serotonin receptors have been recognised which differ in their pharmacology, molecular biology, and mode of action.
(12 Dec 1998)
receptors, sigma A class of cell surface receptors recognised by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known (although they can react to certain endogenous steroids). Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues.
(12 Dec 1998)
receptors, somatomedin Cell surface receptors that bind somatomedins and trigger intracellular changes which influence the behaviour of cells. Studies have disclosed two types of receptors for this family of peptide hormones. The type I receptor is homologous to the insulin receptor and has tyrosine kinase activity. The type II receptor is identical to the mannose-6-phosphate receptor which is important in trafficking of lysosomal enzymes.
(12 Dec 1998)
receptors, somatostatin Cell surface proteins that bind somatostatin and trigger intracellular changes which influence the behaviour of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin's role as a neurotransmitter.
(12 Dec 1998)
receptors, somatotropin Cell surface proteins that bind somatotropin with high affinity and trigger intracellular changes influencing the behaviour of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins.
(12 Dec 1998)
receptors, steroid Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behaviour of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes.
(12 Dec 1998)
receptors, tachykinin Cell surface proteins that bind tachykinins with high affinity and trigger intracellular changes influencing the behaviour of cells. Three classes of tachykinin receptors have been characterised, the nk-1, nk-2, and nk-3, which prefer, respectively, substance p, neurokinin a (substance k, neurokinin alpha, neuromedin l), and neurokinin b (neurokinin beta, neuromedin k).
(12 Dec 1998)
receptors, thrombin Cell surface proteins that specifically bind thrombin and trigger changes in the behaviour of blood cells. There are at least two types of thrombin receptors on platelets. The higher affinity receptors mediate the inhibition of stimulated adenylate cyclase, the secretion of acid hydrolases, and the activation of phospholipase a2. The lower affinity receptors are linked to phospholipase c and trigger platelet aggregation and exposure of fibrinogen binding sites. A human platelet thrombin receptor has been cloned and is a member of the family of peptide receptors. There are also thrombin receptors on endothelial cells and smooth muscle cells.
(12 Dec 1998)
receptors, thromboxane Cell surface proteins that bind thromboxanes with high affinity and trigger intracellular changes influencing the behaviour of cells. at least a subset of thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems.
(12 Dec 1998)
receptors, thyroid hormone Proteins, usually found in the nucleus, that specifically bind thyroid hormones and regulate DNA transcription. These proteins, termed c-erba, are activated by hormones and cause differentiation of erythroid progenitor cells which irreversibly lose proliferative potential. Thus c-erba proteins act as growth suppressors. The c-erba proteins are encoded by at least two genes, c-erba alpha and c-erba beta. Each of these has two isoforms. Mutations in the ligand-binding domain of the beta form causes thyroid hormone resistance syndrome.
(12 Dec 1998)
receptors, thyrotropin Cell surface proteins that bind thyrotropin and trigger intracellular changes influencing the behaviour of cells. These receptors are present in the nervous system and on cells in the thyroid gland. Autoantibodies to these receptors are implicated in graves', hashimoto's, and other thyroid diseases.
(12 Dec 1998)
receptors, thyrotropin-releasing hormone Cell surface receptors that bind thyrotropin releasing hormone (trh) with high affinity and trigger intracellular changes which influence the behaviour of cells. Activated trh receptors in the anterior pituitary stimulate the release of thyrotropin (thyroid stimulating hormone, tsh). Trh receptors on neurons mediate neurotransmission by trh.
(12 Dec 1998)
receptors, transferrin Membrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released.
(12 Dec 1998)
receptors, transforming growth factor beta Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behaviour of cells. Two types of transforming growth factor receptors have been recognised. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action. Transforming growth factor alpha binds to the same receptors as epidermal growth factor (see receptors, epidermal growth factor-urogastrone).
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 19
  • Receptor, TIE-1 - »õâ A TIE receptor found predominantly on ENDOTHELIAL CELLS. It is considered essential for vascular development and can form a heterodimer with the TIE-2 RECEPTOR. The TIE-1 receptor may play a role in regulating BLOOD VESSEL stability and maturation.
    Synonyms : TIE1 Tyrosine Kinase, Receptor, TIE 1, TIE 1 Receptor Tyrosine Kinase, TIE-1 Receptor, Tyrosine Kinase, TIE1
  • Receptor, TIE-2 - »õâ A TIE receptor tyrosine kinase that is found almost exclusively on ENDOTHELIAL CELLS. It is required for both normal embryonic vascular development (NEOVASCULARIZATION, PHYSIOLOGIC) and tumor angiogenesis (NEOVASCULARIZATION, PATHOLOGIC).
    Synonyms : Angiopoietin Receptor Tie-2, TIE-2-RTK, TIE2 Tyrosine Kinase, Tek Receptor, Tie2 Receptor, Angiopoietin Receptor Tie 2, Receptor Tie-2, Angiopoietin, Receptor, TIE 2, Receptor, Tek, Receptor, Tie2, TIE 2 Receptor Tyrosine Kinase, TIE-2 Receptor
  • Receptor, trkA - »õâ A protein-tyrosine kinase receptor that is specific for NERVE GROWTH FACTOR; NEUROTROPHIN 3; neurotrophin 4, neurotrophin 5. It plays a crucial role in pain sensation and thermoregulation in humans. Gene mutations that cause loss of receptor function are associated with congenital insensitivity to pain with anhidrosis, while gene rearrangements that activate the protein-tyrosine kinase function are associated with tumorigenesis.
    Synonyms : Neurotrophic Tyrosine Kinase Receptor Type 1, Proto-Oncogene Products c-trk, c-trk Protein, gp140 c-trk, p140-trkA, trk1 Transforming Tryrosine Kinase, Proto Oncogene Products c trk, Proto Oncogene Protein trk, Proto-Oncogene Protein, trk, Receptor, NTRK1
  • Receptor, trkB - »õâ A protein-tyrosine kinase receptor that is specific for BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; neurotrophin 4 and neurotrophin 5. It is widely expressed in nervous tissue and plays a role in mediating the effects of neurotrophins on growth and differentiation of neuronal cells.
    Synonyms : Neurotrophic Tyrosine-Kinase Receptor Type 2, trkB(gp145) Protein, Brain Derived Neurotrophic Factor Receptor, Receptor, BDNF, Receptor, NTRK2
  • Receptor, trkC - »õâ A protein-tyrosine kinase receptor that is specific for NEUROTROPHIN 3. It is widely expressed in nervous tissue and may play a role in mediating the effects of NEUROTROPHIN 3 on the proliferation and differentiation of NEURONS.
    Synonyms : NTRK3 Protein, Neurotrophic Tyrosine-Kinase-Receptor Type 3, trkC Protein, Kinase TRKC, Protein-Tyrosine, Protein Tyrosine Kinase TRKC, Receptor, NTRK3, Receptor, Neurotrophin 3, TRKC, Protein-Tyrosine Kinase
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
º£³×ÇȽºÁÖ - »õâ
Çѱ¹¿ÍÀ̾
E30540401 Recombinant blood coagulation factor IX
Àü¹®ÀǾàǰ | »èÁ¦
·¹ÇÁ·ç´ÜÁÖ»ç50mg - »õâ
ºñ¿¤¾Ø¿¡ÀÌÃë
E26130021 Lepirudin
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
¸®ÄÞºñ³×ÀÌÆ® - »õâ
¹Ú½ºÅÍ
E04270381 Recombinant blood coagulation factor VIII
Àü¹®ÀǾàǰ | ±Þ¿©
¹Ù¹Ìµå - »õâ
Çѱ¹ÇÁ¶óÀÓÁ¦¾à
Rebamipide
Àü¹®ÀǾàǰ | ºñ±Þ¿©
¸®Æä¹Î¿¡ÇÁÁ¤ - »õâ
±¹Á¦¾àǰ°ø¾÷
A03051251 Cimicifuga fluid extract, Hyperici 80% methanol dried extract
ÀϹÝÀǾàǰ | »èÁ¦
·¹¸Þ·Ð¼ÖÅÇÁ¤30mg - »õâ
N.V. Organon
E02170571 Mirtazapine
Àü¹®ÀǾàǰ | ±Þ¿©
·¹¸Þ·Ð¼ÖÅÇÁ¤15mg - »õâ
N.V. Organon
E02170561 Mirtazapine
Àü¹®ÀǾàǰ | ±Þ¿©
·¹¹Ì½ºÅ¸Á¤ - »õâ
µ¿±¸Á¦¾à
A11193611 Rebamipide
Àü¹®ÀǾàǰ | »èÁ¦
·¹¹Ì½ºÆ®Á¤ - »õâ
ÇÏ¿øÁ¦¾à
A25803161 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
¾È±¹·¹¹Ù¹ÌÇǵåÁ¤ - »õâ
¾È±¹¾àǰ
A08504321 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
receiver set that receives radio or tv signals liquidator: (law) a person (usually appointed by a court of law) who liquidates assets or preserves them for the benefit of affected parties telephone receiver: earphone that converts electrical signals into sounds recipient: a person who gets something a football player who catches (or is supposed to catch) a forward pass
Ãâó: wordnet.princeton.edu/perl/webwn
refraction the change in direction of a propagating wave (light or sound) when passing from one medium to another deflection: the amount by which a propagating wave is bent
Ãâó: wordnet.princeton.edu/perl/webwn
reinforcer reinforcing stimulus: (psychology) a stimulus that strengthens or weakens the behavior that produced it
Ãâó: wordnet.princeton.edu/perl/webwn
reproducibility the quality of being reproducible
Ãâó: wordnet.princeton.edu/perl/webwn
resonance an excited state of a stable particle causing a sharp maximum in the probability of absorption of electromagnetic radiation a vibration of large amplitude produced by a relatively small vibration near the same frequency of vibration as the natural frequency of the resonating system plangency: having the character of a loud deep sound; the quality of being resonant rapport: a relationship of mutual understanding or trust and agreement between people the quality imparted to voiced speech sounds by the action of the resonating chambers of the throat and mouth and nasal cavities
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • reassume
    ´Ù½Ã ÃëÇÏ´Ù;´Ù½Ã ÀμöÇÏ´Ù;Àç°¡Á¤ÇÏ´Ù;´Ù½Ã ½ÃÀÛÇÏ´Ù
  • reassumption
    µÇãÀ½;ÀçÀμö;Àç°¡Á¤;Àç°³½Ã
  • reassurance
    ¾È½É
  • reassurance
    ¾È½ÉÇÔ(½ÃÅ´);¾Èµµ;(»õ·Î¿î)ÀÚ½Å;È®½Å;À纸Áõ;À纸Çè(reinsurance)
  • reassure
    ¾È½É½ÃŰ´Ù
  • reassure
    ¾È½É½ÃŰ´Ù;´Ù½Ã ¿ë±â¸¦ ³»°Ô ÇÏ´Ù;´Ù½Ã ÀÚ½ÅÀ» °®°ÔÇÏ´Ù;À纸ÁõÇÏ´Ù;=REINSURE
  • reassuring
    ¾È½É½ÃŰ´Â
  • reassuring
    ¾È½É½ÃŰ´Â;¿ë±â¸¦ µ¸¿ì´Â;°í¹«ÀûÀÎ(encouraging);À§¾ÈÀ» ÁÖ´Â;~ly
  • Reaum
    Reaumur
  • Reaumur
    ¿­¾¾ ÇѶõ°èÀÇ
  • reave
    ¾àÅ»ÇÏ´Ù;°­Å»ÇÏ´Ù;...¿¡°Ô¼­ »©¾Ñ´Ù(bereave);»©¾Ñ´Ù;reaver
  • reawaken
    ´Ù½Ã °¢¼º½ÃŰ´Ù(ÇÏ´Ù)
  • REB
    relativistic electron beam »ó´ë·ÐÀû ÀüÀÚ ºö(500keVÀÌ»ó °í¿¡³ÊÁö ÀüÀÚ ºö)
  • reb
    ³²±º º´»ç(Johnny Reb);³²ºÎ ¹éÀÎ
  • Reba
    (¿©ÀÚÀ̸§)(RebeccaÀÇ ¾ÖĪ)
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 19
RE data processing fast enough to keep up with an outside process
RE data processing fast enough to keep up with an outside process
RE a rare soft orange mineral consisting of arsenic sulphide
RE align anew or better
RE align anew or better
RE something that is made real or concrete
RE making real or giving the appearance of reality
RE a sale in order to obtain money (as a sale of stock or a sale of the estate of a bankrupt person) or the money so obtained
RE coming to understand something clearly and distinctly
RE perceive mentally, as of an idea
RE be fully aware or cognizant of
RE make real or concrete
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 19
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á